CIK 0001657677 · <br>Emerging growth company
Parabilis Medicines, Inc.
Sign in to watch- Ticker
- PBLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474505725
- Phone
- 617-945-9510
- Business address
- 30 ACORN PARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA, 02140
- Former names
- FOG PHARMACEUTICALS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-22 | Tendler Craig Director | Grant or award · Stock Option (Right to Buy) | +20,294 | 20,294 | ||
| 2026-07-22 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +47,250 | $29.77 | $1.4M | 26,529,686 |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +21,696 | $27.96 | $607K | 26,438,209 |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +6,504 | $29.17 | $190K | 26,444,713 |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +37,723 | $30.00 | $1.1M | 26,482,436 |
| 2026-07-20 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +98,433 | $27.13 | $2.7M | 26,383,526 |
| 2026-07-20 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +32,987 | $27.72 | $914K | 26,416,513 |
| 2026-06-15 | SEBULSKY ALAN Director | Purchase | +5,000 | $26.00 | $130K | 25,935 |
| 2026-06-15 | SEBULSKY ALAN Director | Purchase | +4,065 | $27.10 | $110K | 30,000 |
| 2026-06-12 | SEBULSKY ALAN Director | Purchase | +8,435 | $27.67 | $233K | 20,935 |
| 2026-06-11 | Levy Guy 10% owner | Purchase | +375,000 | $20.00 | $7.5M | 1,027,000 |
| 2026-06-11 | Levy Guy 10% owner | Purchase | +125,000 | $20.00 | $2.5M | 652,000 |
| 2026-06-11 | Levy Guy 10% owner | Conversion | +527,070 | $9.48 | $5.0M | 527,070 |
| 2026-06-11 | Levy Guy 10% owner | Conversion · Series F Preferred Stock | −527,070 | 0 | ||
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +6,556,740 | 6,556,740 | ||
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +1,187,881 | 1,187,881 | ||
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +19,728,353 | $20.00 | $394.6M | 26,285,093 |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,460,397 | $20.00 | $29.2M | 2,648,278 |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series E Preferred Stock | −642,250 | 0 | ||
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series E Preferred Stock | −160,562 | 0 |
Page 1 of 3 · 55 trades